We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Rexford Industrial Realty
REXR
$8.12B
| $356K | ﹤0.01% |
+6,838
| New | +$423K |
|
1027
MarineMax
HZO
$1.15B
| $352K | ﹤0.01% |
11,827
-19,690
| -62% | -$737K |
|
|
AFCG
1028
AFC Gamma
AFCG
$68.7M
| $351K | ﹤0.01% |
33,559
-41,875
| -56% | -$483K |
|
|
AGNT
1029
AGNT Inc
AGNT
$752M
| $351K | ﹤0.01% |
31,325
-17,171
| -35% | -$239K |
|
1030
Coherent
COHR
$64B
| $349K | ﹤0.01% |
10,021
+1,751
| +21% | +$83.9K |
|
1031
First Industrial Realty Trust
FR
$8.4B
| $349K | ﹤0.01% |
+7,787
| New | +$394K |
|
1032
M/I Homes
MHO
$3.9B
| $349K | ﹤0.01% |
9,628
-4,918
| -34% | -$212K |
|
|
GBIO
1033
DELISTED
Generation Bio
GBIO
| $347K | ﹤0.01% |
6,533
| – | – |
|
1034
Olin
OLN
$2.17B
| $346K | ﹤0.01% |
8,060
-668,553
| -99% | -$33.9M |
|
1035
Park Aerospace
PKE
$811M
| $346K | ﹤0.01% |
31,319
-50,978
| -62% | -$602K |
|
|
VGR
1036
DELISTED
Vector Group Ltd.
VGR
| $344K | ﹤0.01% |
39,057
-150,886
| -79% | -$1.53M |
|
|
MORF
1037
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $344K | ﹤0.01% |
+12,143
| New | +$338K |
|
1038
GE Aerospace
GE
$374B
| $342K | ﹤0.01% |
8,865
| – | – |
|
1039
CoStar Group
CSGP
$13.4B
| $338K | ﹤0.01% |
4,850
| – | – |
|
|
FRBK
1040
DELISTED
Republic First Bancorp Inc
FRBK
| $336K | ﹤0.01% |
118,688
| – | – |
|
|
CSTR
1041
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $334K | ﹤0.01% |
18,018
| – | – |
|
1042
Rigel Pharmaceuticals
RIGL
$762M
| $333K | ﹤0.01% |
28,224
+3,781
| +15% | +$51.1K |
|
1043
Raymond James Financial
RJF
$34.8B
| $333K | ﹤0.01% |
3,369
-48,731
| -94% | -$4.93M |
|
1044
Uber
UBER
$155B
| $333K | ﹤0.01% |
12,562
-2,202
| -15% | -$60.8K |
|
1045
Domino's
DPZ
$11.6B
| $331K | ﹤0.01% |
1,068
| – | – |
|
1046
Amphastar Pharmaceuticals
AMPH
$858M
| $330K | ﹤0.01% |
11,755
| – | – |
|
1047
i3 Verticals
IIIV
$325M
| $327K | ﹤0.01% |
16,350
| – | – |
|
1048
Phreesia
PHR
$780M
| $327K | ﹤0.01% |
12,847
+4,226
| +49% | +$105K |
|
1049
Douglas Emmett
DEI
$1.99B
| $323K | ﹤0.01% |
18,014
-24,882
| -58% | -$530K |
|
1050
iRhythm Holdings
IRTC
$4.06B
| $323K | ﹤0.01% |
2,575
-2,976
| -54% | -$430K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.